[CML] Phase I Study Results of Investigational Agent BMS-354825 in Patients With Imatinib-Resistant or Intolerant Chronic Myelogenous Leukemia Presented at the 46th Annual Meeting of the American Society of Hematology

[Rob]

Phase I data presented today at the 46th annual meeting of the American Society of Hematology showed that patients with Philadelphia chromosome positive chronic myelogenous leukemia (CML) who are resistant or intolerant to imatinib mesylate (Gleevec(R))* experienced hematologic and cytogenetic responses with Bristol-Myers Squibb Company's oral investigational anti-cancer agent BMS-354825.   http://cmlsupport.blogspot.com/2005/01/phase-i-study-results-of.html New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: cml@yahoogroups.com Subscribe:  [EMAIL PROTECTED] Unsubscribe:  [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED]  CML Group Web Site http://groups.yahoo.com/group/CML Yahoo! Groups Links To visit your group on the web, go to: http://groups.yahoo.com/group/CML/   To unsubscribe from this group, send an email to: [EMAIL PROTECTED]   Your use of Yahoo! Groups is subject to the Yahoo! Terms of Service.